Visual and absorbance analyses of admixtures containing vancomycin and piperacillin-tazobactam at commonly used concentrations.

CONCLUSION: Visual, microscopic, and absorbance analyses showed no evidence of incompatibility when piperacillin-tazobactam 33.75-90 mg/mL was combined with vancomycin ≤7 mg/mL. Reversible and irreversible precipitates formed when piperacillin-tazobactam was combined with vancomycin ≥8 mg/mL. PMID: 26843502 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/26843502?dopt=Abstract

Source: American Journal of Health-System Pharmacy : AJHP - February 9, 2016 Category: Drugs & Pharmacology Authors: O'Donnell JN, Venkatesan N, Manek M, Rhodes NJ, Scheetz MH Tags: Am J Health Syst Pharm Source Type: research

More News: Drugs & Pharmacology | Health | Zosyn